Journal: Biomacromolecules
Article Title: Development of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms
doi: 10.1021/acs.biomac.4c00321
Figure Lengend Snippet: Immunofluorescence (CD68, FSP-1, MECA-32, αSMA, and DAPI) images of 3 weeks after the embolization ( n = 4): (A) HA-VS/Gel-SH with 10% iohexol, and (B) HA-VS/Gel-SH with 10% iohexol and RADA-SP (scale bar: 100 μm, *: middle of aneurysm sac).
Article Snippet: The samples were double stained with CD68 (ab53444, rat antimouse recombinant antibody, Abcam, 1:100) and FSP-1 (ab197896, rabbit antimouse recombinant antibody, Abcam, 1:125) and also MECA32 (ab27853, rat antimouse recombinant antibody, Abcam, 1:500) and αSMC (ab5694, rabbit antimouse recombinant antibody, Abcam, 1:100).
Techniques: Immunofluorescence